Douglas W. Pagan, Chief Financial Officer at Paratek Pharmaceuticals, Inc. (PRTK), sold 3,405 shares at $15.20 ($51K) on 2017-02-06, disclosed to the SEC on 2017-02-08.
Scheduled sale ($51k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.05 | 1,186 | $18K | 34.7% |
| 2 | $15.08 | 17 | $256 | 0.5% |
| 3 | $15.09 | 25 | $377 | 0.7% |
| 4 | $15.10 | 1,428 | $22K | 42.0% |
| 5 | $15.15 | 732 | $11K | 21.6% |
| 6 | $15.20 | 17 |
| $258 |
| 0.5% |
| Total | $15.09 avg | 3,405 | $51K | 100% |
| Filing → |
| PRTK | SELL | 2018-10-16 | $25K | — | Filing → |
| PRTK | SELL | 2018-10-04 | $149K | — | Filing → |
| PRTK | SELL | 2018-04-10 | $133K | — | Filing → |